 Meghan O'Meara
Concepts (79)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sheep | 5 | 2012 | 828 | 0.280 |
Why?
| | Amino Acids | 3 | 2012 | 476 | 0.220 |
Why?
| | Insulin | 4 | 2012 | 2316 | 0.160 |
Why?
| | Fetus | 3 | 2012 | 760 | 0.150 |
Why?
| | Insulin-Secreting Cells | 2 | 2012 | 367 | 0.150 |
Why?
| | Gluconeogenesis | 1 | 2012 | 73 | 0.100 |
Why?
| | Maternal-Fetal Exchange | 2 | 2012 | 161 | 0.100 |
Why?
| | Malnutrition | 1 | 2012 | 79 | 0.090 |
Why?
| | Leucine | 1 | 2012 | 108 | 0.090 |
Why?
| | Glucose | 2 | 2012 | 983 | 0.090 |
Why?
| | Pancreas | 1 | 2012 | 304 | 0.090 |
Why?
| | Fetal Blood | 1 | 2012 | 316 | 0.080 |
Why?
| | Pulmonary Alveoli | 1 | 2011 | 365 | 0.080 |
Why?
| | Hypoglycemia | 1 | 2012 | 425 | 0.070 |
Why?
| | Organ Size | 3 | 2012 | 440 | 0.070 |
Why?
| | Endothelial Cells | 1 | 2011 | 700 | 0.060 |
Why?
| | Fetal Growth Retardation | 1 | 2011 | 543 | 0.060 |
Why?
| | Pulmonary Artery | 1 | 2011 | 1030 | 0.060 |
Why?
| | Pregnancy | 6 | 2012 | 6355 | 0.060 |
Why?
| | Liver | 1 | 2012 | 1826 | 0.050 |
Why?
| | Infusions, Intravenous | 2 | 2012 | 390 | 0.050 |
Why?
| | Random Allocation | 2 | 2012 | 342 | 0.040 |
Why?
| | Lactic Acid | 2 | 2012 | 294 | 0.040 |
Why?
| | Gestational Age | 2 | 2012 | 868 | 0.040 |
Why?
| | Blood Glucose | 3 | 2012 | 2092 | 0.040 |
Why?
| | Oxidation-Reduction | 2 | 2012 | 1001 | 0.030 |
Why?
| | Animals | 6 | 2012 | 34487 | 0.030 |
Why?
| | Insulin Resistance | 2 | 2012 | 1164 | 0.030 |
Why?
| | Animals, Inbred Strains | 1 | 2012 | 7 | 0.030 |
Why?
| | Sheep, Domestic | 1 | 2012 | 34 | 0.030 |
Why?
| | Amino Acids, Branched-Chain | 1 | 2012 | 36 | 0.030 |
Why?
| | Cell Size | 1 | 2012 | 87 | 0.030 |
Why?
| | Electrolytes | 1 | 2012 | 58 | 0.030 |
Why?
| | Fetal Weight | 1 | 2012 | 56 | 0.020 |
Why?
| | Glucagon-Secreting Cells | 1 | 2012 | 24 | 0.020 |
Why?
| | Solutions | 1 | 2012 | 148 | 0.020 |
Why?
| | Phosphoenolpyruvate Carboxykinase (ATP) | 1 | 2012 | 15 | 0.020 |
Why?
| | Glucose-6-Phosphatase | 1 | 2012 | 31 | 0.020 |
Why?
| | Acid-Base Equilibrium | 1 | 2012 | 27 | 0.020 |
Why?
| | Glucagon | 1 | 2012 | 105 | 0.020 |
Why?
| | Blood Gas Analysis | 1 | 2012 | 71 | 0.020 |
Why?
| | Pulmonary Gas Exchange | 1 | 2012 | 118 | 0.020 |
Why?
| | Cell Aggregation | 1 | 2011 | 26 | 0.020 |
Why?
| | Hyperinsulinism | 1 | 2012 | 119 | 0.020 |
Why?
| | Tissue Distribution | 1 | 2012 | 295 | 0.020 |
Why?
| | Hormones | 1 | 2012 | 140 | 0.020 |
Why?
| | Vascular Endothelial Growth Factor Receptor-2 | 1 | 2011 | 81 | 0.020 |
Why?
| | Receptor, Insulin | 1 | 2011 | 99 | 0.020 |
Why?
| | Placental Insufficiency | 1 | 2012 | 111 | 0.020 |
Why?
| | Arginine | 1 | 2012 | 259 | 0.020 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2012 | 323 | 0.020 |
Why?
| | Primary Cell Culture | 1 | 2011 | 157 | 0.020 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2011 | 197 | 0.020 |
Why?
| | Cell Hypoxia | 1 | 2011 | 228 | 0.020 |
Why?
| | Time Factors | 2 | 2012 | 6479 | 0.020 |
Why?
| | Female | 6 | 2012 | 68016 | 0.020 |
Why?
| | Down-Regulation | 1 | 2012 | 630 | 0.020 |
Why?
| | Carbon Dioxide | 1 | 2012 | 258 | 0.020 |
Why?
| | Blood Vessels | 1 | 2011 | 181 | 0.020 |
Why?
| | Infusion Pumps | 1 | 2009 | 31 | 0.020 |
Why?
| | Up-Regulation | 1 | 2012 | 822 | 0.020 |
Why?
| | Blotting, Western | 1 | 2012 | 1169 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2011 | 419 | 0.020 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2011 | 499 | 0.020 |
Why?
| | Kinetics | 1 | 2012 | 1617 | 0.020 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2012 | 817 | 0.020 |
Why?
| | Phosphorylation | 1 | 2011 | 1681 | 0.020 |
Why?
| | Cell Movement | 1 | 2011 | 933 | 0.020 |
Why?
| | Gene Expression | 1 | 2011 | 1454 | 0.020 |
Why?
| | Nitric Oxide | 1 | 2011 | 881 | 0.020 |
Why?
| | Dietary Supplements | 1 | 2009 | 531 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2012 | 2669 | 0.010 |
Why?
| | Cell Proliferation | 1 | 2011 | 2337 | 0.010 |
Why?
| | Hypoglycemic Agents | 1 | 2012 | 1212 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2011 | 4006 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2012 | 3936 | 0.010 |
Why?
| | Algorithms | 1 | 2009 | 1609 | 0.010 |
Why?
| | Lung | 1 | 2011 | 3745 | 0.010 |
Why?
| | Signal Transduction | 1 | 2011 | 4812 | 0.010 |
Why?
|
|
O'Meara's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|